Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
7
self-reported 2–10 band
Founded
2021
5 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
1
Seed · Aug 2021 · US$ 9.7M
Company type
Privately Held
self-reported
Description
Amaroq Therapeutics is a New Zealand-based biotechnology company focused on developing a new class of therapeutics that target lncRNA in cancer.
Long non-coding RNAs are a relatively recently discovered class of molecules often referred to as “dark matter” of the human genome. These naturally occurring molecules do not code for proteins but fulfill important regulatory functions in the cell that could be exploited as a new therapeutic approach for multiple indications. Amaroq’s research team has discovered lncRNA molecules that are highly expressed in cancer cells, and once removed, cancer cell growth slows. Amaroq Therapeutics is developing innovative therapeutics to target lncRNAs for cancer treatment.
Amaroq Therapeutics is funded by the Medical Research Commercialisation Fund, managed by life science venture capital firm Brandon Capital Partners, Otago Innovation Ltd, University of Otago, Cure Kids, and NZ Innovation Booster. The Company has been spun out of research from the University of Otago in Dunedin, New Zealand.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | NZ |
All codes: NZ
Addresses
- NZ15 Customs St W; Level 22, PwC Tower; Auckland, 1010Primary
Grid intelligence Members
Funding
Rounds1
Round typeSeed · venture round
Amount (USD)9,700,000
Stage rank2
Investors named1
Since last round4 yr 5 mo
Funding
Show as table · 1 funding round
| Rounds | 1 |
|---|---|
| Axis | 2021 to 2026 |
| Seed · 8 Aug 2021 | US$ 9.7M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
3 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
How many people work at Amaroq Therapeutics?
7 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Where does Amaroq Therapeutics have offices?
One address on record, New Zealand only. Primary: 15 Customs St W, Level 22, PwC Tower, Auckland 1010.
Has Amaroq Therapeutics raised funding?
One round. Latest 8 August 2021: Seed, US$9,700,000, investor Brandon Capital Partners.
Which companies are listed alongside Amaroq Therapeutics?
Nine peer profiles on record: BioOra and Aroa Biosurgery Limited.